Cerenome, Inc. (CNSY) Sees Preliminary Q3 CNSide Gross Billings of $1.55M
Cerenome reported preliminary Q3 2026 CNSide gross billings of $1.55M, noting gross billings are not GAAP revenue and may differ from final results.Material DetailsContext by AI AnalystThis is an early datapoint on building a reimbursed diagnostics business post-integration of CNSide. A confirmed r…